Read about our innovations and milestones, our expansions and experts, our commitment and idea sharing, or in brief: about everything that moves us.
July 28, 2017
GROWTH:

Precisis AG successfully increases capital

Precisis AG is investing in the clinical phase of its product development EASEE®. The medical technology company has increased its share capital to approximately 1.5 million Euros for this purpose. The increase in stock gives it a gross revenue of approximately 3.5 million Euros.
July 3, 2017
SUCCESS:

Initial tests confirm good tolerance

An initial short-term study performed in an outpatient setting at selected epilepsy centres in Germany shows that the EASEE® stimulation works well and is well-tolerated.
January 3, 2017
RECOGNITION:

Senate of science prizes innovative passion

Dr Angela Liedler, chairwoman and owner of the EASEE® manufacturer Precisis AG was appointed a member of the Senate of Economy in Germany. The community of values brings together solution-driven people from a wide variety of industries.